Atlas Trials

Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up

Clinical trial NCT03487900 · UNKNOWN

Trial details

NCT number
NCT03487900
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
CD
Start date
2018-03-13
Primary completion
2023-12-31
Enrollment
320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.